Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vice President's Council on Competitiveness

Executive Summary

House votes (236-183) on July 1 to eliminate the staff budget of $86,000 for Vice President Quayle's council. The vote was on an amendment to the FY 1993 Treasury/General Government appropriations bill, which cleared the House later that day. A November 1991 report on ways to improve the drug approval process is one example of the council's efforts to review federal regulations and promote policies to enhance industry competitiveness, but some legislators contend the council exerts undue influence on the activities of federal agencies and lacks public accountability ("The Pink Sheet" Nov. 18, 1991, p. 4). President Bush has threatened to veto the entire spending measure unless funding is restored.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021147

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel